Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke. (2022)

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-022-33675-1

PubMed Identifier: 36253349

Publication URI: http://europepmc.org/abstract/MED/36253349

Type: Journal Article/Review

Volume: 13

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723